{"name":"Tilray","slug":"tilray","ticker":"","exchange":"","domain":"","description":"Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand,Latin America, with growing facilities in Germany, Portugal and the United Kingdom.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":821309000,"revenueGrowth":4.1,"grossMargin":0,"rdSpend":284000,"netIncome":-2186738000,"cash":2074327000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxObTRMQUxDNHJqT3JQU1I4VG82NG5GLWlhLXRMbTZTZ1NrX19WZkkwQXAzVllicjAzTEdpNmdxeGNtXzk3MWsycGk0NDVFRHdHckJJaVBYc2N6aGFHRFdCZ0hNbzNnOXRLaWsxQjRJSWlzdVBmcTM5VU9ZVW9zUkxaUlZwZ29OakFaejNCem9pdEEwSF84dzFGLTNwdExkblNKekl5RmZJU05hUlZuODNBb1FB?oc=5","date":"2026-04-06","type":"earnings","source":"TipRanks","summary":"Tilray Earnings Call Highlights Growth Amid Margin Pressures - TipRanks","headline":"Tilray Earnings Call Highlights Growth Amid Margin Pressures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNNHRCdzd0S1BtUGRabzFNOFByaDJVekx1aS1GNHdpcURkS3NIYUw0TG9LWXVVLWxEekgxalNlOW1QbHBmamQyaUdqYVFJejVPT3BHbFFVSzlQTDh2eDN0UTdOV1dCdEd2TF8ycFo0dGlJVWpQZHpyYy1PYVM5UVUxZDVVOXFhc2IxZWoydWhFdzhaQVlUT1RHU084TEJBWHRadzd5TnJPLVgweEJJRVV1ZVRBZDQ?oc=5","date":"2026-04-02","type":"earnings","source":"TradingView","summary":"Should Tilray Brands Be in Your Portfolio Post Q3 Earnings? - TradingView","headline":"Should Tilray Brands Be in Your Portfolio Post Q3 Earnings?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNVzBKOUlCMzJmbmhZYmp6Z3FZS3BJOGtlRWYyWFZ5UjloMlBrNTFFWThTOWt1Z19oVUV1M2MxN3M0U2pUSWRqQnBlY2pqRTlxR0JNdDhlYTBaaTc3S2tHYmpCT0dOeFFienNtSVpZN2h1UDQ4bVp0NElFMldtZFZzeWtHc1dUZzhwckthRFZHVkZlcGVVeVFEVk1QSQ?oc=5","date":"2026-04-01","type":"earnings","source":"MarketBeat","summary":"Tilray Brands Q3 Earnings Call Highlights - MarketBeat","headline":"Tilray Brands Q3 Earnings Call Highlights","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQT1VIVlk1MkZSa2kzQVg0S0t6QWJMOHh2bEs4eTdsa1pMUGhQSEd2Yzg4RjlPNmRRMnpMTXVPVDNRTUlyNGVtX2JCdUJXazUwQk5NdmRmLXJxNEsyMU1FYVg1amhoM0VtSjdIT3Fzd056d0QyTENHMjRsSy1uSE5LdzRSdnR1Rld0c1ZZVGtrUVk2RjBBbjNLUllwRHNIdEFZd1lYVEpFOUo1M1JDSlFpeHRITzZVZkNoR3dTYnE2VFhVUy1OcWh6Mm1TQWZOV1BmQkFOdllvaEpGN25PWmRRVQ?oc=5","date":"2026-04-01","type":"earnings","source":"TradingView","summary":"Tilray Brands posts record Q3 revenue $206.7M; gross profit $55.0M, adjusted EBITDA $10.7M - TradingView","headline":"Tilray Brands posts record Q3 revenue $206.7M; gross profit $55.0M, adjusted EBITDA $10.7M","sentiment":"neutral"},{"date":"2026-04-01","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-04-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNT0pTZU9YZGp3b3d6RGZZbE5TSGdaVXUtYXBTMjN0bU4xWENMeUVVU0laVU0yWE53ZzFpTF9adzZpd3EzZEJIT2hPRGxjblRmZTJpMjNQZGxMdy0tWWNXLXBWV0hNR0QySjRyMnNJa2IzUi1QMlZBLVh5WVBNbTlOOWZzazRKWHNvUkRaM0FBU1dQZDVONUFybmx0d2dxazl6Y3YzLVZNWDl0bXRNYjhCTmlsZlJmbV83YWVxUmstWWVTZXpsNW04?oc=5","date":"2026-03-19","type":"pipeline","source":"Cannabis Business Times","summary":"Tilray Medical Expands Medical Cannabis Portfolio in Australia - Cannabis Business Times","headline":"Tilray Medical Expands Medical Cannabis Portfolio in Australia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOMFlhN2VOb3pRSkRtWmtFdnZ3V2xQNXVjVzJDeWozOWJlXzhqbzh0b24zNUlKcnMwMGo1U1pRTXJzcHIwV0NNVmtPSmNDeFk0MjJJQ2I0SlFwNVFMMFJKeTc3MlZQWTh5azdselZqa1dQbGJhY3VvQkJIa0hVdnR0VUZ0LTBkSVhoT3pkWjRmODNXell4MVkwVDZONTZKdTF4bG9NZGtESnhPQ1pYeDFQejA2anllX3ZrWnRWV3FRVjNrVXd2?oc=5","date":"2026-03-19","type":"pipeline","source":"TradingView","summary":"Tilray stock price has just lost a key support: is a crash to $5 coming? - TradingView","headline":"Tilray stock price has just lost a key support: is a crash to $5 coming?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxOSWRkLWRKXzJZT2xOdFlULUkzeEQ2QmxEaHd6NkkyTk1DZS1zRU8yYmJKcEplYl9hcDBqWVNoUWNJNE1kN0RsVl9LUmZid0V5cXE0MXVDekRqaGRSM2JuY3lydGc2SENKN1Z1TnVGTy10eXI3OEtyc2NyVGNNNjN2Ums2elk2MEJQZFBOaHJUY0g0TkVXTjNBaFpOd2ZndGx5cnRQeXY4NUIzYXN5SEdNb2ltdS1ndnRVd1BaLXFZQ0VJa2xXM2YzRzBtYi0yR00xU0tFYlc4dkdNeWJlem85MWN5UnRtcGctVFhDQlZocy0zdGdPbHRGMG55Vkc0SjNQcU0wZDNFWE1SVm9NMXJNRVlaczd6YmRhSlBv?oc=5","date":"2026-03-12","type":"pipeline","source":"Cannabis Business Times","summary":"Tilray Medical, CC Pharma, 14U Pharma Announce Strategic Alliance With ‘gesund leben’ Cooperation, Alliance Healthcare Deutschland - Cannabis Business Times","headline":"Tilray Medical, CC Pharma, 14U Pharma Announce Strategic Alliance With ‘gesund leben’ Cooperation, Alliance Healthcare D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPOVY3WmNrZlBYekJ4NDRud1hYeFRvZUhUSVlBZFNwSUtJN1hNLU5kaU5Ra1lEMDM2b09IaENPTGhHalUyV0ZMQ3JTcEcyTlVVcDM1UVpXVzJJRmV6d1hUT1JlbGsza09CNGFZbzdaX1VLcHU3azh3U0dEejZ1NTJLcHA1bGtpVFBtZ2lqZHdycmFYclNpaFlUMGlzTmxhTTdWQldrYjFtNXFoeHZ3VkczNFotZ1F0dlpYMXpmVV93?oc=5","date":"2026-03-12","type":"deal","source":"Benzinga","summary":"Tilray Expands German Healthcare Push With Strategic Pharma Deal - Benzinga","headline":"Tilray Expands German Healthcare Push With Strategic Pharma Deal","sentiment":"neutral"},{"date":"2026-03-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPelhDVFFKdTJjLUZ2NFZBQ0F2aExBa2YxazFIZHdMdXlCQmFhenVyOFEtdzFXQ3BSNGlJZXNhYlVKdEwwZEI4czlZRWxVYm5SLVhDdnpGV2FRYUxweHdTbUxkUEJadEVXcDg5ZTI4QUR6bnRWQzBpNERmQnZmQnhwcWozUGNZVHlJYWxaYlNDTkg3YWVYNEVJLVRKZXEtckFwMXZzbA?oc=5","date":"2026-02-13","type":"deal","source":"MMJDaily","summary":"Tilray expands UK pharmaceutical access through partnerships - MMJDaily","headline":"Tilray expands UK pharmaceutical access through partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQTll4SmtxbV9JUWVRcFFuZ1RxalJCa2V0YmRNb05WWHZVQURLVlFieTBYVldVVUdNcDFoeDhDSGx4Z0pXcVZHbmdwbjdKc2xvWWl2cGdHbWdpbjJoZF91bGFJM2JnYTBsdW13LUJfX2k0Z1Vud2ZsWmJnTGs3VFNpa3hJQ1BQMUVSLVRTZWt3?oc=5","date":"2026-02-12","type":"pipeline","source":"Yahoo Finance","summary":"Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals - Yahoo Finance","headline":"Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQcWhnMEJpU21yLXkwdk8zQXI0YnJHTXZJTGpfQmJ0V3JtQVBpYjk0cnJOUUJaS1VvZE1jRGsxN0ZMN213QzRkTElvMDI1VjdDVFRQdmRZenpUUHo1LXpsNTF3Nkw5ME5IQ0Jzc3BJS1ZrMWFJSFVleU42dlFWTjRvV0JYS0lrMlZNSFRGcFZIaHhvT0p3cjQ3a0FKa0RYa2IzejZ6YXRKbjN3RmtCSzNfemc1YmsxZnZNOU1rLUZxZw?oc=5","date":"2026-02-12","type":"pipeline","source":"Stock Titan","summary":"Tilray–Smartway pact aims to steady UK medicine supplies - Stock Titan","headline":"Tilray–Smartway pact aims to steady UK medicine supplies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOSnJvMUIwamNsN01WRHpuZDR6VVRjVEVjUUhxVDIxbmlLZFRxVFRaLVpaTjgzcDZqSjlJNnB0ODBzZGV6NExreGh3Y0puSkNxcWdiVXhUTVk2NWdBZHNVNWtQRFZoVVBzak5jZU1vMS1rQlBwRlp4WThZLVZ0aHdXUEhMLVU4WUtDeG9GRw?oc=5","date":"2026-02-07","type":"pipeline","source":"Yahoo Finance","summary":"Tilray Builds Medical Cannabis And Spirits Pillars As Share Performance Lags - Yahoo Finance","headline":"Tilray Builds Medical Cannabis And Spirits Pillars As Share Performance Lags","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":821309000,"revenuePeriod":"2025-05-31","revenueHistory":[{"value":821309000,"period":"2025-05-31"},{"value":788942000,"period":"2024-05-31"},{"value":788942000,"period":"2024-05-31"},{"value":627124000,"period":"2023-05-31"},{"value":627124000,"period":"2023-05-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":284000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-2186738000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":2074327000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}